科兴制药：上半年归母净利润8034.45万元，同比增长576.45%

Core Viewpoint - The company reported a decline in revenue for the first half of the year, while net profit saw a significant increase compared to the previous year [1] Financial Performance - The company achieved an operating income of 700 million yuan in the first half of the year, representing a year-on-year decrease of 7.82% [1] - The net profit attributable to shareholders was 80.34 million yuan, a substantial increase of 576.45% from 11.88 million yuan in the same period last year [1] - The basic earnings per share were reported at 0.41 yuan [1]